Loading quotes...
Forecast
The analysts' average price target is €4.48 (-49.89%). The median is €4.48 (-49.89%).
| Buy |
4 |
| Hold |
3 |
| Sell |
4 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 17.66m | 58.04% |
| Gross profit | 16.15m | 45.26% |
| Net profit | -40.93m | 20.00% |
| EBITDA | -38.87m | 0.58% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €603.28m |
Number of shares | 67.34m |
52-week high/low | €16.34 - €4.82 |
| Dividends | No |
Beta | 1.80 |
P/E ratio | -1.99 |
PEG ratio | -0.13 |
P/B ratio | 1.48 |
P/S ratio | 6.01 |
Company profile
| Name | Ginkgo Bioworks Holdings A Aktie |
| CEO | Jason Kelly |
| Employees | 485 |
